Feng He

Feng He


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2018 in Frontiers in Microbiology
Verified
Journal Article
Open access
PDF file
TTTiroyaone Shimane Tshikantwa
Tiroyaone Shimane Tshikantwa
Muhammad Wajid UllahMuhammad Wajid Ullah
Muhammad Wajid Ullah
FHFeng He
Feng He
Guang YangGuang Yang
Guang Yang
For a long time, it was considered that interactions between microbes are only inhibitory in nature. However, latest developments in research have demonstrated that within our environment, several classes of microbes exist which produce different products upon interaction and thus embrace a wider scope of useful and potentially valuable aspects beyond simple antibiosis. Therefore, the current review explores different types of microbial interactions and describes the role of various physical, chemical, biological, and genetic factors regulating such interactions. It further explains the mechanism of action of biofilm formation and role of secondary metabolites regulating bacteria-fungi interaction. Special emphasis and focus is placed on microbial interactions which are important in medicine, food industry, agriculture, and environment. In short, this review reveals the recent contributions of microbial interaction for the benefit of mankind.

1 December 2018 in Industrial Crops and Products
Verified
Journal Article
Closed access
FXFu Xiang
Fu Xiang
JBJinhai Bai
Jinhai Bai
XTXiaobei Tan
Xiaobei Tan
TCTing Chen
Ting Chen
WYWei Yang
Wei Yang
FHFeng He
Feng He

15 September 2020 in Frontiers in Bioengineering and Biotechnology
Verified
Journal Article
Open access
PDF file
WSWasim Sajjad
Wasim Sajjad
FHFeng He
Feng He
Muhammad Wajid UllahMuhammad Wajid Ullah
Muhammad Wajid Ullah
MIMuhammad Ikram
Muhammad Ikram
SSShahid Masood Shah
Shahid Masood Shah
FWFazli Wahid
Fazli Wahid
The current study aimed to fabricate curcumin-loaded bacterial cellulose (BC-Cur) nanocomposite as a potential wound dressing for partial thickness burns by utilizing the therapeutic features of curcumin and unique structural, physico-chemical, and biological features of bacterial cellulose (BC). Characterization analyses confirmed the successful impregnation of curcumin into the BC matrix. Biocompatibility studies showed the better attachment and proliferation of fibroblast cells on the BC-Cur nanocomposite. The antibacterial potential of curcumin was tested against Escherichia coli (E. coli), Pseudomonas aeruginosa (P. aeruginosa), Salmonella typhimurium (S. typhimurium), and Staphylococcus aureus (S. aureus). Wound healing analysis of partial-thickness burns in Balbc mice showed an accelerated wound closure up to 64.25% after 15 days in the BC-Cur nanocomposite treated group. Histological studies showed healthy granulation tissues, fine re-epithelialization, vascularization, and resurfacing of wound bed in the BC-Cur nanocomposite group. These results indicate that combining BC with curcumin significantly improved the healing pattern. Thus, it can be concluded that the fabricated biomaterial could provide a base for the development of promising alternatives for the conventional dressing system in treating burns.

1 January 2021 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
BBBianza Moise Bakadia
Bianza Moise Bakadia
FHFeng He
Feng He
TSTiatou Souho
Tiatou Souho
LLLallepak Lamboni
Lallepak Lamboni
Muhammad Wajid UllahMuhammad Wajid Ullah
Muhammad Wajid Ullah
Guang YangGuang Yang
Guang Yang
The ongoing pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has drawn the attention of researchers and clinicians from several disciplines and sectors who are trying to find durable solutions both at preventive and treatment levels. To date, there is no approved effective treatment or vaccine available to control the coronavirus disease-2019 (COVID-19). The preliminary in vitro studies on viral infection models showed potential antiviral activities of type I and III interferons (IFNs), chloroquine (CQ)/hydroxychloroquine (HCQ), and azithromycin (AZM); however, the clinical studies on COVID-19 patients treated with CQ/HCQ and AZM led to controversies in different regions due to their adverse side effects, as well as their combined treatment could prolong the QT interval. Interestingly, the treatment with type I IFNs showed encouraging results. Moreover, the different preliminary reports of COVID-19 candidate vaccines showcase promising results by inducing the production of a high level of neutralizing antibodies (NAbs) and specific T cell-mediated immune response in almost all participants. The present review aims to summarize and analyze the recent progress evidence concerning the use of IFNs, CQ/HCQ, and AZM for the treatment of COVID-19. The available data on immunization options to prevent the COVID-19 are also analyzed with the aim to present the promising options which could be investigated in future for sustainable control of the pandemic.

31 January 2023 in Molecules
Verified
Journal Article
Open access
PDF file
SWShuzhen Wang
Shuzhen Wang
FHFeng He
Feng He
HWHongmei Wu
Hongmei Wu
FXFu Xiang
Fu Xiang
HZHongyan Zheng
Hongyan Zheng
Shiming LiShiming Li
Shiming Li
Polygonati Rhizoma, a typical homology of medicine and food, possesses remarkable anti-fatigue, anti-aging, metabolic regulatory, immunomodulatory, anti-inflammatory, neuroprotective, anti-diabetes, and anti-cancer effects. Among bioactive phytochemicals in Polygonati Rhizoma, polysaccharides play important roles in the health-promoting activities through the mechanisms mentioned above and potential synergistic effects with other bioactives. In this review, we briefly introduce the updated biosynthesis of polysaccharides, the purification method, the structure characterization, and food applications, and discuss in detail the biological activities of Polygonati Rhizoma polysaccharides and associated mechanisms, aiming at broadening the usage of Polygonati Rhizoma as functional food and medicine.

1 March 2019 in LWT
Verified
Journal Article
Closed access
FHFeng He
Feng He
KLKe Li
Ke Li
XZXiaohong Zhang
Xiaohong Zhang
YYYing Yang
Ying Yang
YFYuanping Fang
Yuanping Fang
FXFu Xiang
Fu Xiang